Testing effectiveness (Phase 2)WithdrawnNCT01236456
What this trial is testing
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University